https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-01-01 / Anticancer Res. 2015 Jan;35(1):555-62
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-01-01 / Anticancer Res. 2015 Jan;35(1):555-622015-01-01 00:00:002019-02-15 08:52:28Prognostic markers for patient outcome following vaccination with multiple MHC Class I/II-restricted WT1 peptide-pulsed dendritic cells plus chemotherapy for pancreatic cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-12-11 / Hepat Oncol 2014 Oct;1(4):433-446
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-12-11 / Hepat Oncol 2014 Oct;1(4):433-4462014-12-11 00:00:002014-12-11 00:00:00Immunotherapy of hepatocellular carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-12-03 / Expert Rev Clin Immunol 2015 Feb;11(2):213-32
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-12-03 / Expert Rev Clin Immunol 2015 Feb;11(2):213-322014-12-03 00:00:002019-02-15 08:39:34Dendritic cell-based vaccine research against cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-11-27 / Cancer Res Treat 2015 Jul;47(3):518-26
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-11-27 / Cancer Res Treat 2015 Jul;47(3):518-262014-11-27 00:00:002019-02-15 08:46:10Improved Efficacy of a Dendritic Cell-Based Vaccine against a Murine Model of Colon Cancer: The Helper Protein Effect
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-11-26 / Biomaterials 2015 Feb;40:88-97
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-11-26 / Biomaterials 2015 Feb;40:88-972014-11-26 00:00:002019-02-15 08:39:35CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-11-15 / Immunobiology 2015 Feb;220(2):243-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-11-15 / Immunobiology 2015 Feb;220(2):243-82014-11-15 00:00:002019-02-15 08:39:36Restoring immunosurveillance by dendritic cell vaccines and manipulation of the tumor microenvironment
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-11-07 / Eur. J. Immunol. 2014 Dec;44(12):3585-95
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-11-07 / Eur. J. Immunol. 2014 Dec;44(12):3585-952014-11-07 00:00:002019-02-15 08:45:48Natural killer and dendritic cells collaborate in the immune response induced by the vaccine against uterine cervical cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-11-01 / Curr Opin Oncol 2014 Nov;26(6):608-14
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-11-01 / Curr Opin Oncol 2014 Nov;26(6):608-142014-11-01 00:00:002019-02-15 08:46:20Perspectives for immunotherapy in glioblastoma treatment
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-11-01 / EMBO Mol Med 2014 Nov;6(11):1359-70
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-11-01 / EMBO Mol Med 2014 Nov;6(11):1359-702014-11-01 00:00:002019-02-15 08:47:43Emerging treatment strategies for glioblastoma multiforme
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-10-31 / Oncoimmunology 2015 Aug;4(8):e970462
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-10-31 / Oncoimmunology 2015 Aug;4(8):e9704622014-10-31 00:00:002019-02-15 08:45:09Antigen targeting to dendritic cells combined with transient regulatory T cell inhibition results in long-term tumor regression
